Literature DB >> 356683

Flunisolide nasal spray for the treatment of children with seasonal allergic rhinitis.

E L Strem, S Austrian, G R Geller, J D Johnson, S Crepea.   

Abstract

Forty-eight children with seasonal allergic rhinitis received either 150 microgram/day of flunisolide (a new topical steroid) or placebo. Those receiving flunisolide had a significantly shorter daily duration of sneezing, stuffy nose, runny nose and throat itch. Total or substantial control of their symptoms was reported by 67% of the flunisolide group and 25% of the placebo group.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 356683

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  3 in total

1.  Pharmacology of nasal medications: an update.

Authors:  G F Martin
Journal:  Can Fam Physician       Date:  1988-12       Impact factor: 3.275

2.  Flunisolide: a review of its pharmacological properties and therapeutic efficacy in rhinitis.

Authors:  G E Pakes; R N Brogden; R D Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-06       Impact factor: 9.546

Review 3.  Topical nasal steroids for intermittent and persistent allergic rhinitis in children.

Authors:  J J Al Sayyad; Z Fedorowicz; D Alhashimi; A Jamal
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.